| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70546 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2002-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9960922de6356fad304b8d4b1c599796
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e4700eb8211d05b7d43fc22fb869fe4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97fbeeeb128b33455780521f257e47bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a749ce9078d823903be672b52037ad1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c355ab73b57a1e635c6f6b5d306ebf0a |
| publicationDate |
2006-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7122318-B2 |
| titleOfInvention |
Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
| abstract |
The present invention provides a system for testing the influence of a drug on integrin expression, which comprises measuring an integrin expression level in platelets of an individual to which the drug is administered and, based on the measured expression amount, determining what effect the drug has on integrin expression in cells other than platelets. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8741920-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004235866-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8143271-B2 |
| priorityDate |
2001-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |